ASAvanti Sinha

Avanti Sinha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Avanti Sinha has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Amro Hashish

    Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University

    3 shared publications
  • Mohamed El-Gazzar

    Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, United States

    3 shared publications
  • Nubia R. Macedo

    Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA

    3 shared publications
  • Yuko Sato

    Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA

    3 shared publications
  • Amr Mekky

    Department of Gastroenterology and Hepatology, People’s Hospital of Zhengzhou University, and Henan Provincial People’s Hospital, Zhengzhou, Henan, 450003, China

    1 shared publication

Latest Publications

  • Open Access

    Correction: Hashish et al. Development and Validation of a New TaqMan Real-Time PCR for the Detection of Ornithobacterium rhinotracheale. Microorganisms 2022, 10, 341

    by Amro Hashish, Avanti Sinha, Yuko Sato, Nubia R. Macedo, Mohamed El-Gazzar

    The authors would like to make the following corrections to this paper


  • Open Access

    Development and Validation of a New TaqMan Real-Time PCR for the Detection of Ornithobacterium rhinotracheale

    by Amro Hashish, Avanti Sinha, Yuko Sato, Nubia R. Macedo, Mohamed El-Gazzar

    Ornithobacterium rhinotracheale (ORT) has been associated with poultry respiratory disease worldwide. The organism is fastidious and isolation is challenging. One TaqMan real-time PCR (qPCR) assay has been developed for the detection of ORT. However, during validating the ORT qPCR, the assay performance was suboptimal. During the in silico evaluation, deviations from the basic parameters for primers and probes designs (e.g., presence of stable undesirable primer-dimers) were observed. The suboptimal design led to low efficiency and low sensitivity of the assay. Initially, modification on the probe was carried out to improve the performance of the assay. However, the assay’s performance (efficiency and sensitivity) was still suboptimal. In this manuscript, we describe the development of a new qPCR assay and the comparison of its performance with the currently available assay. A highly efficient, sensitive, and specific qPCR assay was developed with approximately 1000-folds reduction in the limit of detection (from 3 × 106 plasmid DNA copies/mL to 1 × 103 plasmid DNA copies/mL). Additionally, the efficiency of the new assay (E = 98.70%) was significantly better than the current assay (E = 73.18%). The newly developed assay is an improved diagnostic tool for the sensitive and efficient diagnosis of ORT from clinical samples.


  • Open Access

    Development and Validation of Two Diagnostic Real-Time PCR (TaqMan) Assays for the Detection of Bordetella avium from Clinical Samples and Comparison to the Currently Available Real-Time TaqMan PCR Assay

    by Amro Hashish, Avanti Sinha, Amr Mekky, Yuko Sato, Nubia R. Macedo, Mohamed El-Gazzar

    Bordetella avium (BA) is one of many pathogens that cause respiratory diseases in turkeys. However, other bacterial species can easily overgrow it during isolation attempts. This makes confirming the diagnosis of BA as the causative agent of turkey coryza more difficult. Currently, there are two PCR assays for the molecular detection of BA. One is conventional gel-based PCR and the other is TaqMan real-time PCR (qPCR) assay. However, multiple pitfalls were detected in both assays regarding their specificity, sensitivity, and efficiency, which limits their utility as diagnostic tools. In this study, we developed and validated two TaqMan qPCR assays and compared their performance to the currently available TaqMan qPCR. The two assays were able to correctly identify all BA isolates and showed negative results against a wide range of different microorganisms. The two assays were found to have high efficiency with a detection limit of approximately 1 × 103 plasmid DNA Copies/mL with high repeatability and reproducibility. In comparison to the currently available TaqMan qPCR assay, the newly developed assays showed significantly higher PCR efficiencies due to superior primers and probes design. The new assays can serve as a reliable tool for the sensitive, specific, and efficient diagnosis of BA.